ADGM (Adagio Medical Holdings, Inc Common Stock) Stock Analysis - SEC Filings

Adagio Medical Holdings, Inc Common Stock (ADGM) is a publicly traded Healthcare sector company. As of May 21, 2026, ADGM trades at $0.85 with a market cap of $19.62M and a P/E ratio of -0.58. ADGM moved +0.00% today. Year to date, ADGM is -18.08%; over the trailing twelve months it is -28.49%. Its 52-week range spans $0.63 to $4.20. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces ADGM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ADGM SEC filings?

Rallies organizes ADGM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ADGM Key Metrics

Key financial metrics for ADGM
MetricValue
Price$0.85
Market Cap$19.62M
P/E Ratio-0.58
EPS$-1.51
Dividend Yield0.00%
52-Week High$4.20
52-Week Low$0.63
Volume54
Avg Volume0
Revenue (TTM)$0
Net Income$-25.08M
Gross Margin0.00%

Latest ADGM News

Recent ADGM Insider Trades

  • Kaster Deborah bought 15.00K (~$17.97K) on Dec 16, 2025.
  • Usen Todd bought 207.31K (~$225.97K) on Dec 12, 2025.

ADGM Analyst Consensus

2 analysts cover ADGM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.

Common questions about ADGM

Where can I find ADGM SEC filings?
Rallies organizes ADGM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ADGM 10-K and 10-Q filings?
Rallies organizes ADGM SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ADGM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ADGM. It does not provide personalized investment advice.
ADGM

ADGM